Aurora Cannabis Inc.

TSX:ACB Canada Healthcare — Drug Manufacturers - Specialty & Generic

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plan…

Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the full company research view.
Results 2026-06-11
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA
News release - English.pdf
Results 2026-06-11
Annual information form - English.pdf
Results 2026-06-11
Annual MD&A - English.pdf
Results 2026-06-11
Audited annual financial statements – English.pdf
News 2026-05-14
Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
News release - English.pdf
News 2026-04-28
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
News release - English.pdf
Transactions 2026-04-16 M&A
Aurora Cannabis Inc. Completes Acquisition of Safari Flower Company for $26.5 Million
Material change report - English.pdf
Transactions 2026-04-15 M&A
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets
News release - English.pdf
News 2026-03-30
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
News release - English.pdf
News 2026-02-17
Aurora to Participate in the TD Cowen 46th Annual Health Care Conference
News release - English.pdf
Transactions 2026-02-12 Financing
Aurora Cannabis Inc. Enters into ATM Offering Agreement for up to US$100,000,000
Material change report - English.pdf
Transactions 2026-02-12 M&A
Aurora Cannabis Enters into Agreement to Exchange Bevo Agtech Common Shares for Preferred Shares
Material change report - English.pdf
Transactions 2026-02-04
Prospectus (non pricing) supplement (ATM) – English.pdf
Results 2026-02-04 Financials
Interim MD&A - English.pdf
Results 2026-02-04 Financials
Interim financial statements/report – English.pdf
Results 2026-02-04
Aurora Cannabis Announces Fiscal 2026 Third Quarter Results
News release - English.pdf
News 2026-02-04
Other material contract(s).pdf
Transactions 2026-02-04 Financing
Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program
News release - English.pdf
News 2026-02-04
Consent letter of issuer's legal counsel.pdf
Transactions 2026-02-04
Prospectus (non pricing) supplement (ATM) – English.pdf
News 2026-02-04
Auditors' consent letter.pdf
News 2026-02-04
Auditors' consent letter.pdf
News 2026-01-14
Aurora Achieves Significant Progress in Disease Resistance Research
News release - English.pdf
Results 2025-11-05 Financials
Interim MD&A - English.pdf
Results 2025-11-05 Financials
Interim financial statements/report – English.pdf
News 2025-11-05
News release - English.pdf
News 2025-10-22
News release - English.pdf
Ownership 2025-09-24
Schick, Lori sold +$52k
Insider trading – 2025-09-24
1 insider · −$52k net
News 2025-09-18
News release - English.pdf
News 2025-08-08
News release - English.pdf
Results 2025-08-06 Financials
Interim MD&A - English.pdf
Results 2025-08-06 Financials
Interim financial statements/report – English.pdf
News 2025-08-06
News release - English.pdf
News 2025-07-30
News release - English.pdf
News 2025-07-23
News release - English.pdf
News 2025-07-14
News release - English.pdf
News 2025-07-09
News release - English.pdf
News 2025-07-09
Other.pdf
Ownership 2025-06-24
Jerome, Andre bought +$47k
Insider trading – 2025-06-24
1 insider · +$47k net
News 2025-06-19
News release - English.pdf
News 2025-06-18
News release - English.pdf
News 2025-06-18
News release - English.pdf
Results 2025-06-18 Financials
Annual MD&A - English.pdf
Results 2025-06-18 Financials
Annual information form - English.pdf
Results 2025-06-18 Financials
Audited annual financial statements – English.pdf
Ownership 2025-02-17
2 insiders · −$125k net
Insider trading – 2025-02-17
2 insiders · −$125k net
Ownership 2024-10-01
2 insiders · −$11k net
Insider trading – 2024-10-01
2 insiders · −$11k net
Ownership 2024-09-26
2 insiders · −$173k net
Insider trading – 2024-09-26
2 insiders · −$173k net
Ownership 2024-07-03
2 insiders · $0 net
Insider trading – 2024-07-03
2 insiders · $0 net

Showing 49 of 74 items in this period.